Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

European Network of Pregnancy Registers in Rheumatology (EuNeP)-an overview of procedures and data collection.

Meissner Y, Strangfeld A, Costedoat-Chalumeau N, Förger F, Goll D, Molto A, Özdemir R, Wallenius M, Fischer-Betz R.

Arthritis Res Ther. 2019 Nov 14;21(1):241. doi: 10.1186/s13075-019-2019-3.

2.

Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome.

Angelillo-Scherrer A, Mansouri Taleghani B, Förger F, Baerlocher GM, Pabst T, Pöllinger A, Banz Y, Geiser T, Kremer Hovinga JA, Rovó A.

Blood Adv. 2019 Sep 10;3(17):2664-2667. doi: 10.1182/bloodadvances.2019000465. No abstract available.

3.

No Association of Discontinuing Tumor Necrosis Factor Inhibitors Before Gestational Week Twenty in Well-Controlled Rheumatoid Arthritis and Juvenile Idiopathic Arthritis With a Disease Worsening in Late Pregnancy.

Förger F, Bandoli G, Luo Y, Robinson L, Johnson DL, Chambers CD.

Arthritis Rheumatol. 2019 Jun;71(6):901-907. doi: 10.1002/art.40821. Epub 2019 May 2.

PMID:
30663847
4.

Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort.

Alpizar-Rodriguez D, Förger F, Courvoisier DS, Gabay C, Finckh A.

Rheumatology (Oxford). 2019 Mar 1;58(3):432-440. doi: 10.1093/rheumatology/key311.

PMID:
30380120
5.

Factors Associated With Preterm Delivery Among Women With Rheumatoid Arthritis and Women With Juvenile Idiopathic Arthritis.

Smith CJF, Förger F, Bandoli G, Chambers CD.

Arthritis Care Res (Hoboken). 2019 Aug;71(8):1019-1027. doi: 10.1002/acr.23730. Epub 2019 Jul 4.

PMID:
30133181
6.

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.

Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F.

Arthritis Rheumatol. 2018 Sep;70(9):1399-1407. doi: 10.1002/art.40508. Epub 2018 Jul 22.

7.

Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters.

Zbinden A, van den Brandt S, Østensen M, Villiger PM, Förger F.

Rheumatology (Oxford). 2018 Mar 30. doi: 10.1093/rheumatology/key053. [Epub ahead of print]

PMID:
29617883
8.

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.

Mariette X, Förger F, Abraham B, Flynn AD, Moltó A, Flipo RM, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Helmer E, Wang M, Chakravarty EF.

Ann Rheum Dis. 2018 Feb;77(2):228-233. doi: 10.1136/annrheumdis-2017-212196. Epub 2017 Oct 13.

9.

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study.

Clowse ME, Förger F, Hwang C, Thorp J, Dolhain RJ, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Toublanc N, Wang M, Hale TW.

Ann Rheum Dis. 2017 Nov;76(11):1890-1896. doi: 10.1136/annrheumdis-2017-211384. Epub 2017 Aug 16.

10.

Treatment with biologics during pregnancy in patients with rheumatic diseases.

Förger F.

Reumatologia. 2017;55(2):57-58. doi: 10.5114/reum.2017.67598. Epub 2017 Apr 28. No abstract available.

11.

Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients.

van den Brandt S, Zbinden A, Baeten D, Villiger PM, Østensen M, Förger F.

Arthritis Res Ther. 2017 Mar 20;19(1):64. doi: 10.1186/s13075-017-1269-1.

12.

Rheumatologische Krankheiten und Schwangerschaft.

Förger F.

Ther Umsch. 2016;73(7):385-391. doi: 10.1024/0040-5930/a000808. Review. German. No abstract available.

PMID:
27998251
13.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A.

Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25.

14.

Treatment of rheumatoid arthritis during pregnancy: present and future.

Förger F, Villiger PM.

Expert Rev Clin Immunol. 2016 Sep;12(9):937-44. doi: 10.1080/1744666X.2016.1184973. Epub 2016 May 27. Review.

PMID:
27170517
15.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R, Förger F, Khamashta M, Ruiz-Irastorza G, Zink A, Vencovsky J, Cutolo M, Caeyers N, Zumbühl C, Østensen M.

Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840. Epub 2016 Feb 17.

16.

Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis.

Tham M, Schlör GR, Yerly D, Mueller C, Surbek D, Villiger PM, Förger F.

Arthritis Res Ther. 2016 Jan 22;18:26. doi: 10.1186/s13075-016-0925-1.

17.

Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients.

Förger F, Zbinden A, Villiger PM.

Joint Bone Spine. 2016 May;83(3):341-3. doi: 10.1016/j.jbspin.2015.07.004. Epub 2015 Nov 23.

PMID:
26617214
18.

Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.

Clowse ME, Wolf DC, Förger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U.

J Rheumatol. 2015 Dec;42(12):2270-8. doi: 10.3899/jrheum.140189. Epub 2015 Nov 1.

19.

Differential influence of maternal and fetal pregnancy factors on the in-vitro induction of human regulatory T cells: a preliminary study.

Marcoli N, Østensen M, Portmann-Lanz CB, Surbek D, Villiger PM, Förger F.

Swiss Med Wkly. 2015 Jul 31;145:w14172. doi: 10.4414/smw.2015.14172. eCollection 2015.

20.

State of the art: Reproduction and pregnancy in rheumatic diseases.

Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Förger F, Wahren-Herlenius M, Ruiz-Irastorza G, Koksvik H, Nelson-Piercy C, Shoenfeld Y, Tincani A, Villiger PM, Wallenius M, von Wolff M.

Autoimmun Rev. 2015 May;14(5):376-86. doi: 10.1016/j.autrev.2014.12.011. Epub 2014 Dec 30. Review.

PMID:
25555818
21.

Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases.

Dan D, Fischer R, Adler S, Förger F, Villiger PM.

Swiss Med Wkly. 2014 Oct 23;144:w14030. doi: 10.4414/smw.2014.14030. eCollection 2014.

22.

Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot study.

Adler S, Körner M, Förger F, Huscher D, Caversaccio MD, Villiger PM.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1862-8.

23.

How safe are anti-rheumatic drugs during pregnancy?

Østensen M, Förger F.

Curr Opin Pharmacol. 2013 Jun;13(3):470-5. doi: 10.1016/j.coph.2013.03.004. Epub 2013 Mar 20. Review.

PMID:
23522967
24.

The physiologic increase in expression of some type I IFN-inducible genes during pregnancy is not associated with improved disease activity in pregnant patients with rheumatoid arthritis.

Weix J, Häupl T, Raio L, Villiger PM, Förger F.

Transl Res. 2013 Jun;161(6):505-12. doi: 10.1016/j.trsl.2013.02.007. Epub 2013 Mar 16.

PMID:
23507374
25.

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study.

Möller B, Scherer A, Förger F, Villiger PM, Finckh A; Swiss Clinical Quality Management Program for Rheumatic Diseases.

Ann Rheum Dis. 2014 Apr;73(4):691-6. doi: 10.1136/annrheumdis-2012-202709. Epub 2013 Mar 16.

26.

Pregnancy mediated improvement of rheumatoid arthritis.

Förger F, Vallbracht I, Helmke K, Villiger PM, Østensen M.

Swiss Med Wkly. 2012 Jul 18;142:w13644. doi: 10.4414/smw.2012.13644. eCollection 2012.

27.
28.

Interaction of pregnancy and autoimmune rheumatic disease.

Østensen M, Villiger PM, Förger F.

Autoimmun Rev. 2012 May;11(6-7):A437-46. doi: 10.1016/j.autrev.2011.11.013. Epub 2011 Dec 2. Review.

PMID:
22154710
29.

Evaluation of smell and taste in patients with Wegener's granulomatosis.

Fasunla JA, Hundt W, Lutz J, Förger F, Thürmel K, Steinbach S.

Eur Arch Otorhinolaryngol. 2012 Jan;269(1):179-86. doi: 10.1007/s00405-011-1691-y. Epub 2011 Jul 12.

PMID:
21748655
30.

Treatment with biologics of pregnant patients with rheumatic diseases.

Ostensen M, Förger F.

Curr Opin Rheumatol. 2011 May;23(3):293-8. doi: 10.1097/BOR.0b013e328344a732. Review.

PMID:
21346578
31.

Pregnancy and reproduction in autoimmune rheumatic diseases.

Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A, Förger F, Gordon C, Hahn S, Khamashta M, Lockshin MD, Matucci-Cerinic M, Meroni P, Nelson JL, Parke A, Petri M, Raio L, Ruiz-Irastorza G, Silva CA, Tincani A, Villiger PM, Wunder D, Cutolo M.

Rheumatology (Oxford). 2011 Apr;50(4):657-64. doi: 10.1093/rheumatology/keq350. Epub 2010 Nov 18. Review.

32.

Symmetry in biology: from genetic code to stochastic gene regulation.

Ramos AF, Innocentini GC, Forger FM, Hornos JE.

IET Syst Biol. 2010 Sep;4(5):311-29. doi: 10.1049/iet-syb.2010.0058. Review.

PMID:
20831344
33.

Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis.

Villiger PM, Caliezi G, Cottin V, Förger F, Senn A, Østensen M.

Ann Rheum Dis. 2010 Oct;69(10):1842-4. doi: 10.1136/ard.2009.127423. Epub 2010 Jul 7.

PMID:
20610443
34.

Is IgG galactosylation the relevant factor for pregnancy-induced remission of rheumatoid arthritis?

Förger F, Ostensen M.

Arthritis Res Ther. 2010;12(1):108. doi: 10.1186/ar2919. Epub 2010 Feb 24.

35.

Combined Takayasu arteritis and Hashimoto thyroiditis during 3 consecutive pregnancies.

Adler S, Lahmer T, Heemann U, Förger F.

J Rheumatol. 2009 Jul;36(7):1555-7. doi: 10.3899/jrheum.081300. No abstract available.

PMID:
19567640
36.

Management of RA medications in pregnant patients.

Østensen M, Förger F.

Nat Rev Rheumatol. 2009 Jul;5(7):382-90. doi: 10.1038/nrrheum.2009.103. Epub 2009 Jun 9. Review.

PMID:
19506586
37.

Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role?

Förger F, Villiger PM, Ostensen M.

Arthritis Rheum. 2009 Feb 15;61(2):279-83. doi: 10.1002/art.24161.

38.

[Visual loss and autoimmune disease].

Wiescher A, Seidova SF, Kook P, Maier M, Förger F, Lanzl I.

Ophthalmologe. 2008 Jul;105(7):680-4. doi: 10.1007/s00347-007-1644-4. German. No abstract available.

PMID:
18299843
39.

Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis.

Förger F, Marcoli N, Gadola S, Möller B, Villiger PM, Østensen M.

Ann Rheum Dis. 2008 Jul;67(7):984-90. Epub 2007 Oct 30.

PMID:
17971458
40.

Cytokines and pregnancy in rheumatic disease.

Østensen M, Förger F, Villiger PM.

Ann N Y Acad Sci. 2006 Jun;1069:353-63. Review.

PMID:
16855162
41.

Impact of pregnancy on health related quality of life evaluated prospectively in pregnant women with rheumatic diseases by the SF-36 health survey.

Förger F, Østensen M, Schumacher A, Villiger PM.

Ann Rheum Dis. 2005 Oct;64(10):1494-9. Epub 2005 Mar 18.

42.

Activation markers of peripheral blood mononuclear cells in late pregnancy and after delivery: a pilot study.

Østensen M, Sicher P, Förger F, Villiger PM.

Ann Rheum Dis. 2005 Feb;64(2):318-20.

43.

Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum.

Østensen M, Förger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM.

Ann Rheum Dis. 2005 Jun;64(6):839-44. Epub 2004 Nov 11.

44.

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K.

Ann Rheum Dis. 2004 Sep;63(9):1079-84.

45.
46.

[Wegener's granulomatosis. Formerly poor prognosis, long-term therapy today].

Förger F, Helmke K.

MMW Fortschr Med. 1999 Dec 2;141(48):46-8. German. No abstract available.

PMID:
10728301

Supplemental Content

Loading ...
Support Center